The levels of inflammatory biomarkers in hemodialysis and peritoneal dialysis patients

Creative Commons License

YILDIRIM M., Acikgoz S. B., Genc A. B., YAYLACI S., DHEİR H., SİPAHİ S.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, cilt.67, sa.5, ss.718-723, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 67 Sayı: 5
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1590/1806-9282.20210056
  • Dergi Adı: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.718-723
  • Anahtar Kelimeler: Kidney disease, chronic, End-stage renal disease, Inflammatory markers, CHRONIC KIDNEY-DISEASE, GROWTH-FACTOR 23, BONE-RESORPTION, ADULT PATIENTS, RENAL-FUNCTION, SERUM-LEVELS, I COLLAGEN, KLOTHO, MARKERS, FGF-23
  • Hacettepe Üniversitesi Adresli: Evet

Özet

OBJECTIVE: In this study, we aimed to determine fibroblast growth factor 23, soluble alpha klotho, osteocalcin, indoxyl sulphate, sclerostin, Procollagen 1 N Terminal Propeptide, and beta-CrossLaps levels in hemodialysis and peritoneal dialysis patients, and to compare the levels of these markers among hemodialysis and peritoneal dialysis patients, as well as healthy individuals.